These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19229865)

  • 21. Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells.
    Ortiz RM; Kärkkäinen I; Huovila AP
    Genes Chromosomes Cancer; 2004 Dec; 41(4):366-78. PubMed ID: 15384173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation.
    Jeon OH; Kim D; Choi YJ; Kim SH; Choi WS; Kim DS
    Thromb Res; 2007; 119(5):609-19. PubMed ID: 16797059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.
    Fried D; Böhm BB; Krause K; Burkhardt H
    J Biol Chem; 2012 Jun; 287(25):21214-23. PubMed ID: 22544741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical function for ADAM9 in mouse prostate cancer.
    Peduto L; Reuter VE; Shaffer DR; Scher HI; Blobel CP
    Cancer Res; 2005 Oct; 65(20):9312-9. PubMed ID: 16230393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation.
    Yang X; Meegan JE; Jannaway M; Coleman DC; Yuan SY
    Cardiovasc Res; 2018 Nov; 114(13):1752-1763. PubMed ID: 29939250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells.
    Mattern J; Roghi CS; Hurtz M; Knäuper V; Edwards DR; Poghosyan Z
    Sci Rep; 2019 Aug; 9(1):12540. PubMed ID: 31467400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ADAM15 ectodomain is shed from secretory exosomes.
    Lee HD; Kim YH; Koo BH; Kim DS
    BMB Rep; 2015 May; 48(5):277-82. PubMed ID: 25208722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The therapeutic potential of ADAM15.
    Lucas N; Najy AJ; Day ML
    Curr Pharm Des; 2009; 15(20):2311-8. PubMed ID: 19601833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
    Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
    Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAM15 targets MMP9 activity to promote lung cancer cell invasion.
    Dong DD; Zhou H; Li G
    Oncol Rep; 2015 Nov; 34(5):2451-60. PubMed ID: 26323669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The receptor tyrosine kinases: role in cancer progression.
    Lamorte L; Park M
    Surg Oncol Clin N Am; 2001 Apr; 10(2):271-88, viii. PubMed ID: 11382587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions.
    Herren B; Garton KJ; Coats S; Bowen-Pope DF; Ross R; Raines EW
    Exp Cell Res; 2001 Nov; 271(1):152-60. PubMed ID: 11697891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biological role and regulation of versican levels in cancer.
    Ricciardelli C; Sakko AJ; Ween MP; Russell DL; Horsfall DJ
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):233-45. PubMed ID: 19160015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging roles for proteinases in cancer.
    Noël A; Gilles C; Bajou K; Devy L; Kebers F; Lewalle JM; Maquoi E; Munaut C; Remacle A; Foidart JM
    Invasion Metastasis; 1997; 17(5):221-39. PubMed ID: 9876217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
    Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
    Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of TMPRSS4 during cancer progression.
    Choi SY; Shin HC; Kim SY; Park YW
    Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane type-matrix metalloproteinases and tumor progression.
    Sounni NE; Noel A
    Biochimie; 2005; 87(3-4):329-42. PubMed ID: 15781320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Disintegrin and Metalloprotease 15 is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and may Mediate Angiogenesis.
    Nishimi S; Isozaki T; Wakabayashi K; Takeuchi H; Kasama T
    Cells; 2019 Jan; 8(1):. PubMed ID: 30634456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A disintegrin and metalloproteinase domain-15 deficiency leads to exaggerated cigarette smoke-induced chronic obstructive pulmonary disease (COPD)-like disease in mice.
    Wang X; Rojas-Quintero J; Zhang D; Nakajima T; Walker KH; Peh HY; Li Y; Fucci QA; Tesfaigzi Y; Owen CA
    Mucosal Immunol; 2021 Mar; 14(2):342-356. PubMed ID: 32690871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAM15 modulates outside-in signalling in chondrocyte-matrix interactions.
    Böhm BB; Schirner A; Burkhardt H
    J Cell Mol Med; 2009 Aug; 13(8B):2634-2644. PubMed ID: 18774960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.